Lebbe C - Search Results

1

Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC).

Lebbe C, Garbe C, Stratigos AJ, Harwood C, Peris K, Marmol VD, Malvehy J, Zalaudek I, Hoeller C, Dummer R, Forsea AM, Kandolf-Sekulovic L, Olah J, Arenberger P, Bylaite-Bucinskiene M, Vieira R, Middleton M, Levy A, Eggermont AM, Battistella M, Spano JP, Grob JJ, Pages C; European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organisation for Research and Treatment of Cancer (EORTC). Lebbe C, et al. Eur J Cancer. 2019 Jun;114:117-127. doi: 10.1016/j.ejca.2018.12.036. Epub 2019 May 13. Eur J Cancer. 2019. PMID: 31096150

2

Long-term follow-up of non-HIV Kaposi's sarcoma treated with low-dose recombinant interferon alfa-2b.

Costa da Cunha CS, Lebbe C, Rybojad M, Agbalika F, Ferchal F, Rabian C, Vignon-Pennamen MD, Calvo F, Morel P. Costa da Cunha CS, et al. Among authors: lebbe c. Arch Dermatol. 1996 Mar;132(3):285-90. doi: 10.1001/archderm.132.3.285. Arch Dermatol. 1996. PMID: 8607632

3

Detection of human herpesvirus 8 and human T-cell lymphotropic virus type 1 sequences in Kaposi sarcoma.

Lebbé C, Agbalika F, de Crémoux P, Deplanche M, Rybojad M, Masgrau E, Morel P, Calvo F. Lebbé C, et al. Arch Dermatol. 1997 Jan;133(1):25-30. Arch Dermatol. 1997. PMID: 9006369

4

Molecular analysis of clonality in Kaposi's sarcoma.

Delabesse E, Oksenhendler E, Lebbé C, Vérola O, Varet B, Turhan AG. Delabesse E, et al. Among authors: lebbe c. J Clin Pathol. 1997 Aug;50(8):664-8. doi: 10.1136/jcp.50.8.664. J Clin Pathol. 1997. PMID: 9301550 Free PMC article.

5

Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma.

Lebbé C, Blum L, Pellet C, Blanchard G, Vérola O, Morel P, Danne O, Calvo F. Lebbé C, et al. AIDS. 1998 May 7;12(7):F45-9. doi: 10.1097/00002030-199807000-00002. AIDS. 1998. PMID: 9619797

6

[Kaposi's disease].

Lebbé C. Lebbé C. Rev Prat. 1999 Apr 15;49(8):843-7. Rev Prat. 1999. PMID: 10337197 Review. French.

7

Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.

Pellet C, Chevret S, Blum L, Gauvillé C, Hurault M, Blanchard G, Agbalika F, Lascoux C, Ponscarme D, Morel P, Calvo F, Lebbé C. Pellet C, et al. Among authors: lebbe c. J Invest Dermatol. 2001 Oct;117(4):858-63. doi: 10.1046/j.0022-202x.2001.01465.x. J Invest Dermatol. 2001. PMID: 11676823 Free article.

8

HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation.

Merat R, Amara A, Lebbe C, de The H, Morel P, Saib A. Merat R, et al. Among authors: lebbe c. Int J Cancer. 2002 Feb 20;97(6):791-5. doi: 10.1002/ijc.10086. Int J Cancer. 2002. PMID: 11857356 Free article.

9

Prognostic value of quantitative Kaposi sarcoma--associated herpesvirus load in posttransplantation Kaposi sarcoma.

Pellet C, Chevret S, Francès C, Euvrard S, Hurault M, Legendre C, Dalac S, Farge D, Antoine C, Hiesse C, Peraldi MN, Lang P, Samuel D, Calmus Y, Agbalika F, Morel P, Calvo F, Lebbé C. Pellet C, et al. Among authors: lebbe c. J Infect Dis. 2002 Jul 1;186(1):110-3. doi: 10.1086/341088. Epub 2002 Jun 3. J Infect Dis. 2002. PMID: 12089670

10

[Kaposi's sarcoma].

Boué F, Lebbé C. Boué F, et al. Among authors: lebbe c. Bull Cancer. 2003 May;90(5):393-8. Bull Cancer. 2003. PMID: 12850761 Free article. Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

583 results

Search Page